FungiScope™—Global Emerging Fungal Infection Registry

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Mycoses (Berlin)

• Publication date

  2017-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/myc.12631PMID 28730644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals

  2018cited by this paper
• Molecular and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Characterization of Clinically Significant Melanized Fungi in India

  2017cited by this paper
• Disseminated Fusariosis in Immunocompromised Children-Analysis of Recent Cases Identified in the Global Fungiscope Registry.

  2017cited by this paper
• Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry

  2017cited by this paper
• Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF).

  2016cited by this paper
• Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

  2016cited by this paper
• Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries

  2016cited by this paper
• European Society of Clinical Microbiology and Infectious Diseases

  2016cited by this paper
• Recognizing Data Generation.

  2016cited by this paper
• ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

  2016cited by this paper
• Rhodotorula mucilaginosa as a cause of recurrent pulmonary infection and liver infiltration in a patient with CLL

  2016cited by this paper
• FungiScope TM – Global Emerging Fungal Infection Registry

  2016cited by this paper
• Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes

  2015cited by this paper
• Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality.

  2015cited by this paper
• Using immunohistochemistry to assess the accuracy of histomorphologic diagnosis of aspergillosis and mucormycosis.

  2015cited by this paper
• ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

  2014cited by this paper
• ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

  2014cited by this paper
• Our 2014 approach to mucormycosis

  2014cited by this paper
• ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.

  2014cited by this paper
• ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.

  2014cited by this paper
• Improvement in the outcome of invasive fusariosis in the last decade.

  2014cited by this paper
• European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases.

  2014cited by this paper
• Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries

  2013cited by this paper
• Right flank pain and high fever in a neutropenic patient with acute lymphoblastic leukaemia

  2013cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases.

  2012cited by this paper
• Epidemiology and clinical manifestations of mucormycosis.

  2012cited by this paper
• Comparison of quantitative real time PCR with Sequencing and ribosomal RNA-FISH for the identification of fungi in Formalin fixed, paraffin-embedded tissue specimens

  2011cited by this paper
• Making Moulds Meet Information retrieval as a basis for understanding Pseudallescheria and Scedosporium

  2011cited by this paper
• Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

  2010cited by this paper
• Trends in the postmortem epidemiology of invasive fungal infections at a university hospital.

  2010cited by this paper
• Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

  2010cited by this paper
• Forty-one recent cases of invasive zygomycosis from a global clinical registry.

  2009cited by this paper
• Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.

  2008cited by this paper
• Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

  2008cited by this paper
• The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.

  2006cited by this paper
• An index to quantify an individual's scientific research output

  2005cited by this paper
• F1000Prime recommendation of An index to quantify an individual's scientific research output.

  2005cited by this paper

• Clinical and health economic impact of isavuconazole for treatment of invasive aspergillosis and mucormycosis: a retrospective, matched multicentre cohort study in Germany

  2025cites this paper
• Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States

  2025cites this paper
• Building upon the core elements of antifungal stewardship: practical recommendations for effective antifungal stewardship in resource-limited settings

  2025cites this paper
• Addressing infectious challenges in pediatric cancer and hematopoietic cell transplantation: insights from the Umbrella Working Group

  2025cites this paper
• Sequential serum galactomannan as outcome marker for invasive aspergillosis - an exploratory study from the FungiScope® registry.

  2025cites this paper
• Design and set-up of the leptospirosis registry LeptoScope for epidemiology, outbreaks and clinical studies on human leptospirosis

  2025cites this paper
• Clinical Management and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients: A Multinational Case-control Study

  2024cites this paper
• Invasive fungal infections caused by rare yeast-like fungi in adult patients: results of a prospective study

  2024cites this paper
• Insights from Three Pan-European Multicentre Studies on Invasive Candida Infections and Outlook to ECMM Candida IV

  2024cites this paper
• A case of Magnusiomyces capitatus isolated during monitoring in an antimicrobial diagnostic stewardship context.

  2024cites this paper
• The Development of a Clinical Registry Digital Database on Invasive Fungal Infections in India: Advancing Epidemiological Understanding and Patient Care

  2024cites this paper
• Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study

  2023cites this paper
• Answer to the Photo Quiz: Bloodstream infection in a neutropenic patient with severe aplastic anemia

  2023cites this paper
• Overcoming clinical challenges in the management of invasive fungal infections in low- and middle-income countries (LMIC)

  2023cites this paper
• A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance

  2023cites this paper
• Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-fumigatus Aspergillus spp.

  2023cites this paper
• Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.

  2023cites this paper
• Non-Aspergillus Hyaline Molds: A Host-Based Perspective of Emerging Pathogenic Fungi Causing Sinopulmonary Diseases

  2023cites this paper
• Isavuconazole in the Treatment of Aspergillus fumigatus Fracture-Related Infection: Case Report and Literature Review

  2022cites this paper
• Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study

  2022cites this paper
• Aspergillus tracheobronchitis in COVID-19 ARDS patients - a cohort study.

  2022cites this paper
• Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope

  2022cites this paper
• Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope® registry

  2022cites this paper
• EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Yeast Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation With the International Society for Human and Animal Mycology and American Society for Microbiology

  2021cites this paper
• COVID-19–Associated Pulmonary Aspergillosis, March–August 2020

  2021cites this paper
• Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature

  2021cites this paper
• Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus

  2021cites this paper
• Delivery strategies of amphotericin B for invasive fungal infections

  2021cites this paper
• EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19

  2021cites this paper
• In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.

  2021cites this paper
• Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

  2021cites this paper
• Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada

  2021cites this paper
• Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals

  2021cites this paper
• COVID-19–associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic’s second wave in India

  2021cites this paper
• Aspergillus Tracheobronchitis in COVID-19 ARDS Patients – A Cohort Study

  2021cites this paper
• Bloodstream Infections Caused by Magnusiomyces capitatus and Magnusiomyces clavatus: Epidemiological, Clinical, and Microbiological Features of Two Emerging Yeast Species

  2021cites this paper
• Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope® registry

  2020cites this paper
• Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.

  2020cites this paper
• Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six‐year cohort analysis

  2020cites this paper
• Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope® registry and literature reports

  2020cites this paper
• Genomic and phenotypic analysis of COVID-19-associated pulmonary aspergillosis isolates of Aspergillus fumigatus

  2020cites this paper
• Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope® - Global Registry for Emerging Fungal Infections.

  2020cites this paper
• Mucormycosis in the Middle East and North Africa: Analysis of the FungiScope® registry and cases from the literature

  2020cites this paper
• European confederation of medical mycology expert consult—An ECMM excellence center initiative

  2020cites this paper
• Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.

  2019cites this paper
• Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®

  2019cites this paper
• [Fungal infections].

  2019cites this paper
• Invasive Scedosporium spp. and Lomentospora prolificans Infections in Pediatric Patients: Analysis of 55 Cases from FungiScope® and the Literature.

  2019cites this paper
• Pilzinfektionen

  2019cites this paper
• Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature

  2019cites this paper
• Saprochaete clavata Invasive Infections – A New Threat to Hematological-Oncological Patients

  2019cites this paper
• Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).

  2019cites this paper
• ECMM CandiReg—A ready to use platform for outbreaks and epidemiological studies

  2019cites this paper
• Intravenous and tablet formulation of posaconazole in antifungal therapy and prophylaxis: A retrospective, non-interventional, multicenter analysis of hematological patients treated in tertiary-care hospitals.

  2019cites this paper
• Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans.

  2019cites this paper
• Valley Fever on the Rise—Searching for Microbial Antagonists to the Fungal Pathogen Coccidioides immitis

  2019cites this paper
• Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together

  2018cites this paper
• Challenges in the Diagnosis of Invasive Fungal Infections in Immunocompromised Hosts

  2018cites this paper